Recombinant Drosophila melanogaster Serine protease HTRA2, mitochondrial (HtrA2)

What is the structure and function of Drosophila HtrA2?

Drosophila HtrA2, encoded by the CG8464 gene, is a mitochondrial serine protease of approximately 46 kDa that contains several conserved domains:

• N-terminal mitochondrial targeting sequence (MTS)

• Trans-membrane domain (TM)

• Central protease domain

• C-terminal PDZ domain

• Unconventional IAP-binding motif

Upon import into mitochondria, HtrA2 undergoes proteolytic processing resulting in two cleaved products of 37 and 35 kDa . Functionally, HtrA2 exhibits serine protease activity and can cleave specific peptide substrates similar to its mammalian homologue . When isolated and purified, Drosophila HtrA2 efficiently cleaves the H2-Opt substrate but not control peptides, indicating conserved substrate specificity .

How does HtrA2 contribute to Parkinson's disease pathophysiology?

HtrA2 has been genetically linked to Parkinson's disease (designated as PARK13) through the identification of mutations that lead to loss of protease activity in patient populations . The Drosophila model of HtrA2 deficiency exhibits several PD-like phenotypes:

Importantly, HtrA2 appears to function in a pathway downstream of PINK1 but parallel to Parkin, suggesting it plays a distinct role in mitochondrial quality control mechanisms that are disrupted in PD .

How can I effectively express and analyze recombinant Drosophila HtrA2?

For recombinant expression of Drosophila HtrA2, E. coli expression systems have proven effective. The human version can be expressed as Ala134-Glu458 with a C-terminal 6-His tag , and a similar approach can be applied to the Drosophila ortholog:

Expression Protocol:

• Clone the Drosophila HtrA2 sequence (minus MTS) into a bacterial expression vector with His-tag

• Transform into E. coli expression strain

• Induce protein expression and purify using Ni-NTA chromatography

• Filter solution (0.2 μm) and store in buffer containing HEPES, NaCl, DTT, and glycerol

For storage stability, avoid repeated freeze-thaw cycles and store purified protein at -80°C .

What assays can be used to measure HtrA2 protease activity?

HtrA2 enzymatic activity can be assessed using fluorogenic peptide substrates. The specificity of Drosophila HtrA2 has been demonstrated using the H2-Opt substrate, which is efficiently cleaved compared to control peptides .

Activity Assay Protocol:

• Prepare reaction buffer (typically containing HEPES and NaCl)

• Add purified recombinant HtrA2 (5-50 nM concentration)

• Add fluorogenic peptide substrate H2-Opt (10-50 μM)

• Monitor increase in fluorescence over time using appropriate excitation/emission wavelengths

• Calculate enzymatic activity as relative fluorescence units (RFU) per minute

Control experiments should include heat-inactivated enzyme and non-specific peptide substrates to confirm specificity .

How can I generate and characterize HtrA2 mutant Drosophila models?

Several approaches have been successfully used to generate HtrA2-deficient Drosophila models:

• Precise Excision Mutants: HtrA2Δ1 mutants have been generated through excision of P-element insertions, creating null alleles that can be confirmed by genomic PCR, RT-PCR, and western blot analysis .

• RNA Interference: Knockdown of HtrA2 can be achieved using UAS-RNAi lines expressed with tissue-specific GAL4 drivers. When expressed in dopaminergic neurons, HtrA2 knockdown produces PD-like phenotypes including shortened lifespan and impaired climbing ability .

• Tissue-Specific Expression: The GAL4-UAS system can be used to express wild-type or mutant HtrA2 constructs in specific tissues:

  • TH-GAL4 for dopaminergic neuron expression

  • GMR-GAL4 for eye expression

  • MHC-GAL4 for muscle expression

For phenotypic characterization, the following assays are commonly used:

• Climbing assays to assess locomotor ability

• Lifespan analysis

• Toluidine Blue staining of indirect flight muscles (IFMs)

• Immunostaining for dopaminergic neurons

• Scanning electron microscopy for eye phenotypes

What is the relationship between HtrA2 and other PD-related genes?

Research has established functional connections between HtrA2 and other Parkinson's disease-related genes:

Genetic epistasis experiments suggest that while HtrA2 acts in the PINK1 pathway, it diverges from the PINK1-Parkin axis, pointing to multiple parallel branches of mitochondrial quality control mechanisms .

How can I distinguish between HtrA2's apoptotic and non-apoptotic functions?

Despite previous reports suggesting HtrA2 is a pro-apoptotic factor, evidence from Drosophila models indicates it is dispensable for both developmental and stress-induced apoptosis . To differentiate between its apoptotic and non-apoptotic roles:

Methodological Approach:

• Apoptosis Induction: Expose HtrA2 mutant and control tissues to multiple apoptotic stimuli:

  • γ-rays (4Gy)

  • Staurosporine (4μM)

  • Ultraviolet light (2.5 kJ/m²)

• Apoptosis Detection:

  • Immunostaining for cleaved Caspase-3

  • TUNEL assay

  • Acridine orange staining

• Mitochondrial Function Assessment:

  • Mitochondrial morphology analysis

  • Membrane potential measurement

  • Reactive oxygen species detection

  • Respiration analysis using Seahorse or similar platforms

Results from HtrA2 mutant Drosophila showed normal apoptosis induction following various stimuli, suggesting its primary function lies in maintaining mitochondrial integrity rather than promoting cell death .

What biochemical approaches can be used to identify HtrA2 substrates and interaction partners?

Understanding HtrA2's molecular function requires identification of its substrates and protein interactors:

Substrate Identification:

• Proteomics Approach:

  • Compare protein profiles of wild-type and HtrA2-deficient mitochondria

  • Look for accumulated proteins in HtrA2 mutants that may represent potential substrates

  • Validate using in vitro cleavage assays with recombinant HtrA2

• Candidate Approach:

  • Test known substrates of human HtrA2/Omi

  • Assess potential IAP family proteins (like DIAP1)

  • Examine mitochondrial quality control proteins

Interaction Partners:

• Co-immunoprecipitation of tagged HtrA2 followed by mass spectrometry

• Yeast two-hybrid screening

• Proximity labeling techniques (BioID or APEX) with HtrA2 as the bait protein

Research has demonstrated that HtrA2 forms a complex with PINK1 and is phosphorylated in a PINK1-dependent manner in response to p38 SAPK pathway activation , illustrating how these approaches can reveal functional relationships.

Why might I observe variable phenotypes in HtrA2-deficient models?

Variability in HtrA2 mutant phenotypes has been reported across different studies. Potential causes and solutions include:

For example, one study noted that while they observed mild mitochondrial defects in HtrA2 mutants, another group did not report such defects, possibly due to "allelic or environmental differences" .

How can I optimize experimental conditions for studying stress responses in HtrA2 models?

HtrA2 mutants show increased sensitivity to oxidative stress and mitochondrial toxins . To optimize stress response studies:

Recommended Approach:

• Dose Titration: Determine optimal concentrations of stressors that discriminate between wild-type and HtrA2-deficient flies:

  • Paraquat (oxidative stress inducer)

  • Rotenone (complex I inhibitor)

  • Antimycin A (complex III inhibitor)

  • H₂O₂ (direct oxidative agent)

• Timing: Assess both acute and chronic stress responses:

  • Acute: High dose, short-term exposure (hours)

  • Chronic: Low dose, long-term exposure (days)

• Readouts: Implement multiple phenotypic readouts:

  • Survival curves

  • Locomotor performance

  • ATP levels

  • Mitochondrial morphology

  • ROS production

  • Protein carbonylation

• Rescue Experiments: Test whether overexpression of protective factors like Buffy can suppress stress sensitivity in HtrA2-deficient models

When designing these experiments, include appropriate genetic controls and consider age-dependent effects, as older flies may show enhanced sensitivity to stress challenges.